These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 466214)
41. [Induced labor. A comparative study of prostaglandin gel placed in the cervix and parenteral oxytocin]. Lindholm P Ugeskr Laeger; 1981 Mar; 143(14):878-81. PubMed ID: 7292661 [No Abstract] [Full Text] [Related]
42. [Labor induction with prostaglandin E2 in high-risk pregnancy]. Andreev Zh; Borisov I Akush Ginekol (Sofiia); 1982; 21(1):70-8. PubMed ID: 7044168 [No Abstract] [Full Text] [Related]
43. [Therapeutic abortions in the second trimestre of pregnancy with prostaglandine gel (author's transl)]. Heinzl S Geburtshilfe Frauenheilkd; 1978 Mar; 38(3):220-6. PubMed ID: 640366 [TBL] [Abstract][Full Text] [Related]
44. Prostaglandin E2 vaginal gel--a new formulation for the induction of labour. Gihwala N; Moodley J; Hansen J; Naicker SN S Afr Med J; 1987 Nov; 72(9):615-7. PubMed ID: 3479848 [TBL] [Abstract][Full Text] [Related]
45. Pre-induction ripening of the cervix with extra-amniotic prostaglandin E2 in gel. Thiery M; Parewyck W; De Gezelle H; van Kets H; Smis B; Verheugen C; Gerris J; Voorhoof L; Derom R; Martens G Z Geburtshilfe Perinatol; 1978 Oct; 182(5):352-7. PubMed ID: 735273 [TBL] [Abstract][Full Text] [Related]
46. [Blood coagulation parameters in prostaglandin-induced labour after intrauterine fetal death (author's transl)]. Gruber W Wien Klin Wochenschr; 1978 Aug; 90(15):553-6. PubMed ID: 676315 [TBL] [Abstract][Full Text] [Related]
47. Influence of preinduction prostaglandin E2 vaginal gel on cervical ripening and labor. O'Herlihy C; Macdonald HN Obstet Gynecol; 1979 Dec; 54(6):708-10. PubMed ID: 514556 [TBL] [Abstract][Full Text] [Related]
48. The use of oral prostaglandin E2 to induce labor at term. Gabert HA; Herbertson RM J Reprod Med; 1976 May; 16(5):276-80. PubMed ID: 933107 [TBL] [Abstract][Full Text] [Related]
49. Prostaglandin E2 gel improvement of psoriatic lesions. Remy W; Sigl I; Leipold B Int J Dermatol; 1986 May; 25(4):266-8. PubMed ID: 3458681 [TBL] [Abstract][Full Text] [Related]
50. Use of prostaglandin E2 topical cervical gel in high-risk patients: a critical analysis. Williams JK; Wilkerson WG; O'Brien WF; Knuppel RA Obstet Gynecol; 1985 Dec; 66(6):769-73. PubMed ID: 3906461 [TBL] [Abstract][Full Text] [Related]
52. Fetal death following extra-amniotic prostaglandin gel. Report of two cases. Thiery M Br J Obstet Gynaecol; 1985 Apr; 92(4):427-8. PubMed ID: 3857077 [No Abstract] [Full Text] [Related]
53. Delivery of granulocyte-macrophage colony-stimulating factor in bioadhesive hydrogel stimulates migration of dendritic cells in models of human papillomavirus-associated (pre)neoplastic epithelial lesions. Hubert P; Evrard B; Maillard C; Franzen-Detrooz E; Delattre L; Foidart JM; Noël A; Boniver J; Delvenne P Antimicrob Agents Chemother; 2004 Nov; 48(11):4342-8. PubMed ID: 15504863 [TBL] [Abstract][Full Text] [Related]
54. Prostaglandins in human reproduction. Embrey MP Br Med J (Clin Res Ed); 1981 Dec; 283(6306):1563-6. PubMed ID: 6796167 [No Abstract] [Full Text] [Related]
55. The use of prostaglandin E2 vaginal suppository in missed abortion, intrauterine death and hydatidiform mole. Takagi LR; Gulling EA; O'Leary JA J Med Assoc Ga; 1978 Aug; 67(8):644-5. PubMed ID: 574529 [No Abstract] [Full Text] [Related]
56. Vaginal prostaglandin E2 in the management of fetal intrauterine death. Southern EM; Gutknecht GD; Mohberg NR; Edelman DA Br J Obstet Gynaecol; 1978 Jun; 85(6):437-41. PubMed ID: 350261 [TBL] [Abstract][Full Text] [Related]
57. Management of intrauterine fetal death with prostaglandin E2 vaginal suppositories. Lauersen NH; Cederqvist LL; Wilson KH Am J Obstet Gynecol; 1980 Aug; 137(7):753-7. PubMed ID: 7405965 [TBL] [Abstract][Full Text] [Related]